Junshi Biosciences

Last updated: 13.08.2019


Junshi Bioscieces is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Furthermore, Junshi Biosciences is the first PRC company to obtain NDA approval from the NMPA for the anti-PD-1 monoclonal antibody.



Century Link Block 2, #1705, Shanghai China

Tel: +86 021 50796193




We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here